Michael Monument, MD, MSc, FRCSC

University of Calgary McCaig Bone and Joint Institute, Canada

Poster(s):

• (P 128) INVESTIGATING THE ROLE OF MACROPHAGES IN A MURINE MODEL OF SOFT TISSUE SARCOMA

• (P 142) USE OF SMALL MOLECULE STIMULATE OF TYPE-1 INTERFERON GENES (STING) AGONIST IMMUNOTHERAPY FOR CANINE SARCOMA: A CROSS-SPECIES ANALYSIS

• (P 205) PREOPERATIVE CHEMORADIATION (MODIFIED EILBER PROTOCOL) VERSUS NEOADJUVANT/ ADJUVANT RADIOTHERAPY FOR SOFT TISSUE EXTREMITY SARCOMAS: A POPULATION BASED ANALYSIS IN ALBERTA

• (P 286) INDICATIONS AND LONGEVITY OF ENDOPROSTHETIC RECONSTRUCTIONS FOR PATIENTS WITH METASTATIC BONE DISEASE